Suvretta Capital Management’s Benitec Biopharma BNTC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $116M | Hold |
9,876,506
| – | – | 3.48% | 5 |
|
|
2025
Q1 | $128M | Buy |
9,876,506
+916,497
| +10% | +$11.9M | 4.77% | 3 |
|
|
2024
Q4 | $113M | Buy |
8,960,009
+130,956
| +1% | +$1.65M | 3.86% | 5 |
|
|
2024
Q3 | $81.1M | Buy |
8,829,053
+7,137,763
| +422% | +$65.6M | 2.6% | 8 |
|
|
2024
Q2 | $11.8M | Buy |
1,691,290
+1,487,070
| +728% | +$10.4M | 0.43% | 46 |
|
|
2024
Q1 | $1.07M | Hold |
204,220
| – | – | 0.04% | 84 |
|
|
2023
Q4 | $660K | Hold |
204,220
| – | – | 0.03% | 81 |
|
|
2023
Q3 | $617K | Buy |
204,220
+158,985
| +351% | +$480K | 0.03% | 82 |
|
|
2023
Q2 | $3.12M | Hold |
45,235
| – | – | 0.17% | 66 |
|
|
2023
Q1 | $161K | Hold |
45,235
| – | – | 0.01% | 91 |
|
|
2022
Q4 | $131K | Hold |
45,235
| – | – | 0.01% | 88 |
|
|
2022
Q3 | $286K | Hold |
45,235
| – | – | 0.01% | 70 |
|
|
2022
Q2 | $892K | Hold |
45,235
| – | – | 0.03% | 85 |
|
|
2022
Q1 | $1.8M | Hold |
45,235
| – | – | 0.05% | 76 |
|
|
2021
Q4 | $2.02M | Hold |
45,235
| – | – | 0.04% | 79 |
|
|
2021
Q3 | $2.75M | Hold |
45,235
| – | – | 0.05% | 89 |
|
|
2021
Q2 | $3.27M | Buy |
+45,235
| New | +$3.27M | 0.05% | 98 |
|